Clinical trial NCT06092970 updates: 1. status: ACTIVE_NOT_RECRUITING → TERMINATED 2. completion date: 2026-06-30 → 2026-02-06 3. primary completion date: 2026-06-30 → 2026-02-06 4. enrollment: 379 → 353 participants
Clinical trial NCT05450744 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2026-06-01 → 2027-06-01 3. primary completion date: 2026-06-01 → 2027-06-01
Clinical trial NCT06384352: intervention model: SINGLE_GROUP → PARALLEL.
XCharge North America Powers the Worlds First All-Electric Aircraft Rescue and Firefighting Vehicle at Dallas Love Field Airport
Werner® Earns Double Industry Honors for Outstanding Support of Military Veterans and Families
MHS Serves Announces Recipients of over $2 Million Investment in Hoosier Employment
NeuroSense Issues CEO Letter to Shareholders
NeuroSense Issues CEO Letter to Shareholders
Clinical trial NCT07157423 updates: 1. completion date: 2027-03-26 → 2027-08-26 2. primary completion date: 2027-03-26 → 2027-08-26
Clinical trial NCT07220954 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. completion date: 2027-04-01 → 2027-05-21 3. primary completion date: 2026-09-09 → 2026-09-17 4. enrollment: 21 → 19 participants 5. enrollment type: ESTIMATED → ACTUAL